Page last updated: 2024-11-04

suberoyl bis-hydroxamic acid and Leukemia, Pre-B-Cell

suberoyl bis-hydroxamic acid has been researched along with Leukemia, Pre-B-Cell in 1 studies

suberoyl bis-hydroxamic acid: antineoplastic, Histone Deacetylase inhibitor

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shao, N1
Ma, D1
Wang, J1
Lu, T1
Guo, Y1
Ji, C1

Other Studies

1 other study available for suberoyl bis-hydroxamic acid and Leukemia, Pre-B-Cell

ArticleYear
Notch1 signaling is irresponsible to the anti-leukemic effect of HDACis in B-ALL Nalm-6 cells.
    Annals of hematology, 2013, Volume: 92, Issue:1

    Topics: Acetylation; Apoptosis; B-Lymphocytes; Cell Division; Cell Line, Tumor; Chromatin Assembly and Disas

2013